XML 45 R6.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Cash Flows from Operating Activities    
Net loss $ (2,016,406) $ (4,516,322)
Net loss from discontinued operations (545,103)
Net loss from continuing operations (2,016,406) (3,971,219)
Adjustments to reconcile net loss to net cash provided/(used) by operating activities:    
Depreciation and amortization 1,427,718 2,470,169
Gain/(loss) on disposal of property & equipment 311
Amortization of right-of-use assets 281,758
Change in allowance for inventory obsolescence (19,569)
Change in allowance for doubtful accounts (6,416)
Share-based compensation 143,208 72,216
Interest expense paid in equity shares 1,004,518 163,890
Income tax benefit
Consolidation of equity interest 1,356,495
Loss on equity interests 342,776
Changes in operating assets and liabilities net of effects from acquisition of subsidiaries:    
Accounts receivable (62,013) 1,855,606
Accounts receivable - related party (90) 215,220
Inventory (419,711) (1,393,477)
Prepaid expenses and other curent asstets 20,491 (585,445)
Other assets (834,561) (1,186,589)
Other liabilities (90,121) 9,343
Accounts payable (854,616) 793,113
Deposits from customers 9,166 93,047
Accrued expenses 171,505 509,276
Deferred revenue 227,172 (287,021)
Income taxes payable 102,463 (165,794)
Net cash provided/(used) by operating activities - continuing operations (915,193) 291,606
Net cash provided by operating activities - discontinued operations 2,391,479
Net cash provided/(used) by operating activities (915,193) 2,683,085
Cash Flows from Investing Activities    
Net change in self-insured benefit deposits 166,262 (113,510)
Purchase of property and equipment (4,340,023) (746,056)
Proceeds from sale of marketable securities 398,291
Purchases of treasury stock (190,483)
Net cash used by investing activities - continuing operations (3,965,953) (859,566)
Net cash used by investing activities - discontinued operations (119,482)
Net cash used by investing activities (3,965,953) (979,048)
Cash Flows from Financing Activities    
Proceeds from notes payable 2,990,000
Payments on notes payable (676,640) (214,560)
Proceeds on bank loans 2,476,000
Payments on bank loans (133,414) (615,858)
Proceeds from securities purchase agreements 1,580,100
Expenses on securities purchase agreements (58,950)
Proceeds from at-the-market offerings 360,695
Expenses on at-the-market offerings (18,323)
Proceeds from the issuance of Series B Preferred Stock 500,000
Expenses from the issuance of Series B Preferred Stock (25,000)
Revolving line of credit 387,598 1,387,344
Payments on lease liabilities (293,138) (11,246)
Net cash provided by financing activities - continuing operations 6,271,556 1,363,052
Net cash used by financing activities - discontinued operations (1,417,926)
Net cash provided/(used) by financing activities 6,271,556 (54,874)
Effect of currency translation (184,551) (1,028,760)
Net increase in cash, cash equivalents, and restricted cash 1,390,410 1,649,163
Cash, cash equivalents, and restricted cash at beginning of period 2,858,085 2,315,935
Cash, cash equivalents, and restricted cash at end of period 4,063,944 2,936,338
Balance Sheet Accounts Included in Cash, Cash Equivalents, and Restricted Cash    
Cash and equivalents 2,809,591 1,707,685
Restricted cash 1,254,353 1,228,653
Total cash, cash equivalents, and restricted cash 4,063,944 2,936,338
Supplemental Disclosure of Cash Flow Information:    
Cash paid during the period for interest 342,268 611,444
Cash paid during the period for income taxes 188 31,951
Supplemental Schedule of Non-Cash Investing and Financing Activities    
Stock issued to pay for products and/or services 198,583
Stock issued to pay notes payable 3,632,518 775,000
Dividends paid in equity shares 1,059,650 957,780
Amortization of original issue discounts on notes payable $ 317,667